FDA policies relating to monoclonal antibody products.
2025 · 4th Quarter (Oct 1 - Dec 31)
SPYRE THERAPEUTICS, INC.
Filed by ARNOLD & PORTER KAYE SCHOLER LLP.
Open official filingSource-reported fields
Filing overview
- Type
- Registration
- Posted
- Nov 17, 2025
- Income
- Not reported
- Expenses
- Not reported
- Registrant
- ARNOLD & PORTER KAYE SCHOLER LLP
- Client
- SPYRE THERAPEUTICS, INC.
- Filing UUID
- 846986f0-6c2f-49a9-b418-9339a8003378
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
FDA policies relating to monoclonal antibody products.
FDA policies relating to monoclonal antibody products.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.